Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Baxter International Inc.
DescriptionInactivated, cell-culture seasonal influenza vaccine using Baxter's Vero cell culture technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I/II
Standard IndicationInfluenza virus
Indication DetailsPrevent Influenza virus subtype A and B infection
Regulatory Designation
PartnerTakeda Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today